Chemerin as a marker of subclinical cardiac involvement in psoriatic patients

Aksu F., ÇALIŞKAN M., Keles N., Toprak A. E., Uzuncakmak T. K., Kostek O., ...Daha Fazla

CARDIOLOGY JOURNAL, cilt.24, sa.3, ss.276-283, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5603/cj.a2017.0031
  • Dergi Adı: CARDIOLOGY JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.276-283
  • Anahtar Kelimeler: chemerin, flow-mediated dilatation, epicardial fat tissue, psoriasis, C-REACTIVE PROTEIN, ENDOTHELIAL FUNCTION, CARDIOVASCULAR RISK, METABOLIC SYNDROME, ATHEROSCLEROSIS, DYSFUNCTION, FAT, INFLAMMATION, ASSOCIATION, DISEASE
  • Marmara Üniversitesi Adresli: Hayır

Özet

Background: Chemerin has been associated with psoriasis and inflammation, but there are no studies demonstrating an association between chemerin and subclinical cardiac involvement in psoriatic patients. Therefore, the present study aimed to evaluate whether psoriatic patients with increased epicardial fat tissue, impaired flow-mediated dilatation, and diastolic dysfunction have higher serum chemerin levels than a healthy control group.